Calamos Wealth Management LLC

Position in EXEL — Exelixis, Inc.

CIK 1455258 NAPERVILLE, IL

Position in EXEL

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$217,640

New position

Shares Held

4,000

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#573

of 751 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Calamos Wealth Management LLC holds $11,426,357 across 4 Biotechnology names. EXEL ranks #3 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	188,964	$10,595,211
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,108	$550,376
3	EXEL	Exelixis, Inc. This page	4,000	$217,640
4	CGEN	Compugen Ltd	29,500	$63,130

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$217,640	4,000	—	Shares	Sole	2026-07-31
No filing history on record for this holder in this stock.